Research programme: cancer therapeutics - Plexium
Latest Information Update: 13 Feb 2024
At a glance
- Originator Plexium
- Class Antineoplastics
- Mechanism of Action Proteolysis
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer
Most Recent Events
- 04 Jan 2024 Early research in Cancer in USA (unspecified route) (Plexium pipeline, January 2024)